October 24, 2024
Count Me In and Genome Medical Partner to Provide Genetic Services to Patients Participating in Osteosarcoma and Leiomyosarcoma Research
Partnership provides genetic counseling and testing to patients participating in two Count Me In rare cancer research projects South San Francisco, CA and Cambridge, MA – OCT 24, 2024 – Count Me In, a non-profit cancer research platform led by the Broad Institute of MIT and Harvard, and Genome Medical,…
Read More